Graham Capital Management’s RxSight RXST Stock Holding History

Graham Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Buy	32,063 +5,635	+21%	+$34K	﹤0.01%	1088
2026 Q1	$163K	Buy	26,428 +1,328	+5%	+$11K	﹤0.01%	984
2025 Q4	$262K	Buy	+25,100	New	+$252K	0.01%	925
2025 Q2	–	Sell	-28,403	Closed	-$717K	–	1575
2025 Q1	$717K	Buy	+28,403	New	+$844K	0.01%	659
2024 Q4	–	Sell	-15,985	Closed	-$790K	–	1451
2024 Q3	$790K	Buy	15,985 +4,654	+41%	+$238K	0.01%	523
2024 Q2	$682K	Buy	+11,331	New	+$648K	0.01%	492
2023 Q3	–	Sell	-10,012	Closed	-$288K	–	1255
2023 Q2	$288K	Buy	+10,012	New	+$223K	0.01%	701

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Graham Capital Management's RXST Position: Q2 2026 in Review

Graham Capital Management increased its RxSight (RXST) stake by 21% in Q2 2026, buying an estimated $34K and bringing the position to 32,063 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Graham Capital Management first reported a position in RXST in Q2 2023 and has held it in 7 quarters since. The position peaked at $790K in Q3 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Graham Capital Management held 32,063 shares of RxSight worth $155K as of Q2 2026.
Graham Capital Management bought 5,635 RxSight shares in Q2 2026, an estimated $34K.
RxSight made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1088 holding.
Graham Capital Management first reported a position in RxSight in Q2 2023 and has held it in 7 quarters since.
Graham Capital Management's RxSight position peaked at $790K in Q3 2024.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.